Raltegravir and Paranoia aggravated - a phase IV clinical study of FDA data

Summary:

Paranoia aggravated is reported as a side effect among people who take Raltegravir (raltegravir), especially for people who are male, 50-59 old, also take Sustiva, and have Depression.

The phase IV clinical study analyzes which people have Paranoia aggravated when taking Raltegravir. It is created by eHealthMe based on reports of 5,050 people who have side effects when taking Raltegravir from the FDA, and is updated regularly.

What is Raltegravir?

Raltegravir has active ingredients of raltegravir. eHealthMe is studying from 5,054 Raltegravir users. Check the latest studies of Raltegravir.

What is Paranoia aggravated?

Paranoia aggravated (serious psychotic disorder characterized by delusions of persecution with or without grandeur) is found to be associated with 886 drugs and 337 conditions by eHealthMe. Check the latest studies of Paranoia aggravated.

On Jul, 23, 2026

5,050 people reported to have side effects when taking Raltegravir.
Among them, 17 people (0.34%) have Paranoia aggravated.

Could Raltegravir cause Paranoia aggravated?

Among these 17 people:

What is the gender of people who have Paranoia aggravated when taking Raltegravir? *

female: 0.0 %
male: 100 %

What is the age of people who have Paranoia aggravated when taking Raltegravir? *

What are other drugs people take besides Raltegravir? *

Sustiva: 17 people, 100.00%
Zopiclone: 16 people, 94.12%
Kaletra: 16 people, 94.12%
Emtriva: 16 people, 94.12%
Valproic Acid: 15 people, 88.24%
Clonazepam: 15 people, 88.24%
Risperidone: 15 people, 88.24%
Lamivudine: 14 people, 82.35%
Bupropion Hydrochloride: 12 people, 70.59%
Sertraline: 12 people, 70.59%

What are other side effects people have besides Paranoia aggravated? *

Suicidal Ideation: 17 people, 100.00%
Stress And Anxiety: 17 people, 100.00%
Psychotic Disorder: 17 people, 100.00%
Depression Suicidal (suicide depressive disorder): 17 people, 100.00%
Psychomotor Skills Impaired: 16 people, 94.12%
Tearfulness (excess tearing): 15 people, 88.24%
Psychiatric Decompensation (worsening of symptoms to the state of a serious mental disorder): 15 people, 88.24%
Depressive Symptom: 14 people, 82.35%
Depression: 13 people, 76.47%
Motormental Retardation (a slowing-down of thought and a reduction of physical work): 8 people, 47.06%

What are the existing conditions these people have? *

Hiv Infection: 17 people, 100.00%
Depression: 17 people, 100.00%
Psychotic Disorder: 16 people, 94.12%
Bipolar Disorder (mood disorder): 16 people, 94.12%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Raltegravir and have Paranoia aggravated?

- Check whether Paranoia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Raltegravir:

Raltegravir (5,054 reports)

Browse all side effects of Raltegravir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paranoia aggravated:

Paranoia aggravated (887 drugs)

Browse all the conditions that are associated with Paranoia aggravated:

Paranoia aggravated (337 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raltegravir (the active ingredients of Raltegravir) and Raltegravir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.